Search results
Mankind Pharma is one of the Indian leading pharmaceutical companies, and changes the pharma industry by providing world class medications at affordable prices and maintaining quality standards by using state-of-the-art technology for production of high-quality medicines.
Mankind Pharma focuses on a variety of therapeutic segments such as Cardiovascular, Antibiotics, Gastro-intestinal, Anti-allergic, Anti-fungal, Nutritional, NSAIDs, Ortho and Gynaecological. Every day 75 Lacs Indians consume Mankind's cardiac care products.
Mankind Pharma, is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi, India. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.
9 hours ago · Mankind Pharma Share Price Today: Mankind Pharma shares dropped by 2.5% following the announcement of a Rs 13,630 crore acquisition of Bharat Serums and Vaccines (BSV). The acquisition aims to strengthen Mankind's position in women's health and fertility drugs. BSV reported strong revenue growth in FY24, with a notable presence in IVF and critical care segments.
Mankind Pharma, Best pharmaceutical company in India, has a wide range of products like Antibiotic, Antifungal, NSAIDs, Gastrointestinal, Anthelmintic, Cardiovascular Dermal, Erectile Dysfunction etc.
11 hours ago · Shares of Mankind Pharma settled at Rs 2143.90 on Friday, up 1.81 per cent for the day, with total market capitalization of Rs 86,000 crore. Shares of Mankind Pharma will be in focus during the ...
4 hours ago · Mankind Pharma. Mankind Pharma Ltd. is emerging as the frontrunner to acquire Bharat Serums & Vaccines Ltd. in a deal that could value the target company at around $1.5 billion, according to ...
20 hours ago · Indian drugmaker Mankind Pharma said late on Thursday it would acquire Bharat Serums and Vaccines Ltd in a deal valued at around 136.30 billion rupees ($1.63 billion), including debt.
1 day ago · Mankind Pharma has clinched the deal to acquire Bharat Serums and Vaccines from private equity firm Advent International for ₹13,630 crore, the company said in a release. The Delhi-based pharma ...
20 hours ago · The company has entered into a definitive agreement with Advent to acquire a 100 per cent stake in Bharat Serums and Vaccines (BSV) for an enterprise value of around Rs 13,630 crore, Mankind Pharma said in a statement. With over five decades of leadership in biopharmaceuticals, BSV has developed recombinant and niche biologic products in-house ...
